Colchicine 0.5 mg
Colchicine 0.5 mg is a pharmaceutical drug with 28 clinical trials. Currently 9 active trials ongoing. Historical success rate of 91.7%.
Success Metrics
Based on 11 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
6
Mid Stage
17
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
91.7%
11 of 12 finished
8.3%
1 ended early
9
trials recruiting
28
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral Hemorrhage
Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke
Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease
Effect of Colchicine on Perioperative Anti-inflammatory Organ Injury in Cardiac Surgery
The Effect of Colchicine on the Occurrence of Atrial Fibrillation After Cardiac Surgery
Clinical Trials (28)
Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral Hemorrhage
Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke
Polypill and Colchicine for Risk Reduction in Atherosclerotic Cardiovascular Disease
Effect of Colchicine on Perioperative Anti-inflammatory Organ Injury in Cardiac Surgery
The Effect of Colchicine on the Occurrence of Atrial Fibrillation After Cardiac Surgery
Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis
The Effect of Colchicine on Food-related Effort-based Decision Making in Brain and Behaviour in Overweight and Obesity
Colchicine for Secondary Prevention After Ischemic Stroke (CHANCE-3 EX)
COLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease
The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBAL
Efficacy and Safety of Colchicine After PCI
Effect of Low Dose of Colchicine on Platelet Reactivity
Effect of Colchicine on Progression of Known Coronary Atherosclerosis in Patients With Stable Coronary Artery Disease
Colchicine Use in Intracranial Atherosclerotic Disease
A Study of SSGJ-613 in Gout Subjects Initiating Urate-Lowering Treatment.
ESCALATion of Medical Therapy Following Multimodality Plaque Evaluation in High-risk Chronic Coronary Syndromes
Randomized Double-blind Trial to Study the Benefit of Colchicine in Patients With Acutely Decompensated Heart Failure
Different Doses of Colchicine on hsCRP
COlchicine iN Circulating Inflammatory Markers After StrokE (CONCISE)
Colchicine and Post-COVID-19 Pulmonary Fibrosis
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 28